Sign in
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
Torpedo Maculopathy
Yoshihiro Yonekawa, MD, FASRS
Retina Image Bank: Images of the Week
2020
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Category: Pediatric Retina - ROP